These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 20887681)

  • 21. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
    Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
    Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse induced pluripotent stem cells.
    Geoghegan E; Byrnes L
    Int J Dev Biol; 2008; 52(8):1015-22. PubMed ID: 18956334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
    Desponts C; Ding S
    Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
    Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
    Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.
    Aasen T; Raya A; Barrero MJ; Garreta E; Consiglio A; Gonzalez F; Vassena R; Bilić J; Pekarik V; Tiscornia G; Edel M; Boué S; Izpisúa Belmonte JC
    Nat Biotechnol; 2008 Nov; 26(11):1276-84. PubMed ID: 18931654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of p53-deficient induced pluripotent stem cells from mouse embryo fibroblasts.
    Alexandrova EM; Moll UM
    Methods Mol Biol; 2013; 962():157-64. PubMed ID: 23150445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of human induced pluripotent stem cells from cord blood cells.
    Nishishita N; Takenaka C; Fusaki N; Kawamata S
    J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4.
    Qi H; Pei D
    Cell Res; 2007 Jul; 17(7):578-80. PubMed ID: 17632550
    [No Abstract]   [Full Text] [Related]  

  • 31. Reprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cells.
    Wang WW; Wang W; Jiang Y; Han GF; Lu S; Li G; Zhang J
    Cytotherapy; 2013 May; 15(5):578-85. PubMed ID: 23415920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts.
    Sumer H; Liu J; Malaver-Ortega LF; Lim ML; Khodadadi K; Verma PJ
    J Anim Sci; 2011 Sep; 89(9):2708-16. PubMed ID: 21478453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms.
    Cai Y; Dai X; Zhang Q; Dai Z
    Diagn Pathol; 2015 Apr; 10():35. PubMed ID: 25907774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
    Ho PJ; Yen ML; Lin JD; Chen LS; Hu HI; Yeh CK; Peng CY; Lin CY; Yet SF; Yen BL
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cynomolgus monkey induced pluripotent stem cells established by using exogenous genes derived from the same monkey species.
    Shimozawa N; Ono R; Shimada M; Shibata H; Takahashi I; Inada H; Takada T; Nosaka T; Yasutomi Y
    Differentiation; 2013; 85(4-5):131-9. PubMed ID: 23792767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem cells. A new year and a new era.
    Pera MF
    Nature; 2008 Jan; 451(7175):135-6. PubMed ID: 18185576
    [No Abstract]   [Full Text] [Related]  

  • 38. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
    Xu N; Papagiannakopoulos T; Pan G; Thomson JA; Kosik KS
    Cell; 2009 May; 137(4):647-58. PubMed ID: 19409607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse-induced pluripotent stem cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for ischemic stroke therapy.
    Liu SP; Fu RH; Wu DC; Hsu CY; Chang CH; Lee W; Lee YD; Liu CH; Chien YJ; Lin SZ; Shyu WC
    Stem Cells Dev; 2014 Feb; 23(4):421-33. PubMed ID: 24266622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced pluripotency with endogenous and inducible genes.
    Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
    Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.